Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased

Daily Values

Growth Metrics

SBC Medical Group Holdings (SBC) Share-based Compensation (2024)

SBC Medical Group Holdings filings provide 1 years of Share-based Compensation readings, the most recent being $215237.0 for Q4 2024.

On a quarterly basis, Share-based Compensation changed N/A to $215237.0 in Q4 2024 year-over-year; TTM through Dec 2025 was $13.0 million, a N/A change, with the full-year FY2024 number at $13.0 million, changed N/A from a year prior.
Share-based Compensation hit $215237.0 in Q4 2024 for SBC Medical Group Holdings, down from $12.8 million in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $12.8 million in Q3 2024 to a low of $215237.0 in Q4 2024.